Literature DB >> 19369946

Genetic associations of LYN with systemic lupus erythematosus.

R Lu1, G S Vidal, J A Kelly, A M Delgado-Vega, X K Howard, S R Macwana, N Dominguez, W Klein, C Burrell, I T Harley, K M Kaufman, G R Bruner, K L Moser, P M Gaffney, G S Gilkeson, E K Wakeland, Q-Z Li, C D Langefeld, M C Marion, J Divers, G S Alarcón, E E Brown, R P Kimberly, J C Edberg, R Ramsey-Goldman, J D Reveille, G McGwin, L M Vilá, M A Petri, S-C Bae, S-K Cho, S-Y Bang, I Kim, C-B Choi, J Martin, T J Vyse, J T Merrill, J B Harley, M E Alarcón-Riquelme, S K Nath, J A James, J M Guthridge.   

Abstract

We targeted LYN, a src-tyosine kinase involved in B-cell activation, in case-control association studies using populations of European-American, African-American and Korean subjects. Our combined European-derived population, consisting of 2463 independent cases and 3131 unrelated controls, shows significant association with rs6983130 in a female-only analysis with 2254 cases and 2228 controls (P=1.1 x 10(-4), odds ratio (OR)=0.81 (95% confidence interval: 0.73-0.90)). This single nucleotide polymorphism (SNP) is located in the 5' untranslated region within the first intron near the transcription initiation site of LYN. In addition, SNPs upstream of the first exon also show weak and sporadic association in subsets of the total European-American population. Multivariate logistic regression analysis implicates rs6983130 as a protective factor for systemic lupus erythematosus (SLE) susceptibility when anti-dsDNA, anti-chromatin, anti-52 kDa Ro or anti-Sm autoantibody status were used as covariates. Subset analysis of the European-American female cases by American College of Rheumatology classification criteria shows a reduction in the risk of hematological disorder with rs6983130 compared with cases without hematological disorders (P=1.5 x 10(-3), OR=0.75 (95% CI: 0.62-0.89)). None of the 90 SNPs tested show significant association with SLE in the African American or Korean populations. These results support an association of LYN with European-derived individuals with SLE, especially within autoantibody or clinical subsets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369946      PMCID: PMC2750001          DOI: 10.1038/gene.2009.19

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  27 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus.

Authors:  Fabian Flores-Borja; Panagiotis S Kabouridis; Elizabeth C Jury; David A Isenberg; Rizgar A Mageed
Journal:  Arthritis Rheum       Date:  2005-12

Review 3.  Signalling pathways in B cells: implications for autoimmunity.

Authors:  T Dörner; P E Lipsky
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

4.  The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation.

Authors:  G Texido; I H Su; I Mecklenbräuker; K Saijo; S N Malek; S Desiderio; K Rajewsky; A Tarakhovsky
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women.

Authors:  W J Fessel
Journal:  Arch Intern Med       Date:  1974-12

Review 6.  The epidemiology of systemic lupus erythematosus.

Authors:  M Siegel; S L Lee
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

7.  B-cell kinase lyn deficiency in patients with systemic lupus erythematosus.

Authors:  S N Liossis; E E Solomou; M A Dimopoulos; P Panayiotidis; M M Mavrikakis; P P Sfikakis
Journal:  J Investig Med       Date:  2001-03       Impact factor: 2.895

8.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

9.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979.

Authors:  C J Michet; C H McKenna; L R Elveback; R A Kaslow; L T Kurland
Journal:  Mayo Clin Proc       Date:  1985-02       Impact factor: 7.616

10.  Ethnic difference in the prevalence of systemic lupus erythematosus.

Authors:  H H Hart; R R Grigor; D E Caughey
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

View more
  54 in total

Review 1.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

Review 2.  Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases.

Authors:  Sun Jung Kim
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

3.  IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice.

Authors:  Toni Gutierrez; Jessica M Mayeux; Sterling B Ortega; Nitin J Karandikar; Quan-Zhen Li; Dinesh Rakheja; Xin J Zhou; Anne B Satterthwaite
Journal:  Eur J Immunol       Date:  2012-12-18       Impact factor: 5.532

Review 4.  The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.

Authors:  Wen-Hai Shao; Philip L Cohen
Journal:  Expert Rev Clin Immunol       Date:  2014-03-29       Impact factor: 4.473

5.  A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.

Authors:  Anne B Satterthwaite; Wei Luo; Jessica Mayeux; Toni Gutierrez; Lisa Russell; Andrew Getahun; Jennifer Müller; Thomas Tedder; Jane Parnes; Robert Rickert; Lars Nitschke; John Cambier; Lee Ann Garrett-Sinha
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

6.  LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity.

Authors:  Irina Proekt; Corey N Miller; Marion Jeanne; Kayla J Fasano; James J Moon; Clifford A Lowell; Douglas B Gould; Mark S Anderson; Anthony L DeFranco
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

Review 7.  Recent insights into the genetic basis of systemic lupus erythematosus.

Authors:  Ornella Josephine Rullo; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

Review 8.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 9.  Genetics of rheumatic disease.

Authors:  Alex Clarke; Timothy J Vyse
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

Review 10.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.